Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Coronary Artery Disease
Interventions: Edoxaban 60 mg, Edoxaban 30 mg, Clopidogrel 75 mg, Aspirin 81 mg; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Failed Total Knee Arthroplasty
Interventions: Vitagel; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Alzheimer's Disease, Dementia, Mild Cognitive Impairment
Interventions: PET Scan; Device
Lead sponsor: American College of Radiology; Other
Eligibility: 65 Years and older
Enrollment: 18,488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Femoroacetabular Impingement
Interventions: Hipcheck Software, Conventional Fluoroscopy; Device · Other
Lead sponsor: American Hip Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Acne Vulgaris
Interventions: Visonac PDT, Vehicle cream with PDT; Drug
Lead sponsor: Photocure; Industry
Eligibility: 12 Years to 35 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 15
States / cities: Oceanside, California • San Diego, California • Jacksonville, Florida + 12 more

Conditions: Multidrug Resistant Organisms, Healthcare Associated Infections
Interventions: Quaternary ammonium, Bleach, Quaternary ammonium and UV-C light, Bleach and UV-C light; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 21,395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 9
States / cities: Burlington, North Carolina • Chapel Hill, North Carolina • Durham, North Carolina + 3 more

Conditions: Platelet Inhibition
Interventions: PN400, ASA, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Peripheral Nerve Injuries
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Spondylosis, Cervical Spondylosis, Spondylolisthesis, Herniated Nucleus Pulposus, Degenerative Disc Disease
Interventions: ViBone; Other
Lead sponsor: Elutia Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 4
States / cities: San Diego, California • Danbury, Connecticut • Annapolis, Maryland + 1 more

Conditions: Gall Bladder Diseases
Interventions: NOTES Cholecystectomy, Laparoscopic Cholecystectomy; Procedure
Lead sponsor: Natural Orifice Surgery Consortium for Assessment and Research; Other
Eligibility: 18 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 6
States / cities: San Diego, California • New Haven, Connecticut • Chicago, Illinois + 3 more

Conditions: Health
Interventions: Not listed
Lead sponsor: Buck Institute for Research on Aging; Other
Eligibility: 55 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Novato, California

Conditions: Gastrointestinal Motility Disorder, Intestinal Disease
Interventions: Lanreotide; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: New Hyde Park, New York • New York, New York

Conditions: Breast Cancer
Interventions: LTM - a porcine-based surgical mesh; Device
Lead sponsor: LifeCell; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Chicago, Illinois • Great Neck, New York + 2 more

Conditions: COVID-19 Pandemic
Interventions: Diagnostic Test: IN Vitro; Diagnostic Test
Lead sponsor: 3EO Health; Industry
Eligibility: 2 Years and older
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: Miami, Florida • Humble, Texas • Kingwood, Texas

Conditions: Neuroendocrine Tumors in Lung
Interventions: Lanreotide (Autogel formulation), Placebo, Best Supportive Care; Drug
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 14
States / cities: Tucson, Arizona • Los Angeles, California • Denver, Colorado + 11 more

Conditions: Acute Respiratory Infection, Coronavirus Infection, Influenza
Interventions: Not listed
Lead sponsor: Apple Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Myasthenia Gravis, Generalized
Interventions: mycophenolate mofetil (CellCept), placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 10
States / cities: Sun City, Arizona • Sacramento, California • Miami, Florida + 7 more

Conditions: Endometrial Cancer
Interventions: Fluorescence-guided sentinel lymph node detection; Procedure
Lead sponsor: Swedish Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 3
States / cities: Issaquah, Washington • Seattle, Washington

Conditions: Transcutaneous Oxygen Tension
Interventions: Celliant, Control; Device
Lead sponsor: Kristopher Washington; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Shoulder Pain
Interventions: Indirect MRA of shoulder, Gadopentetate Dimeglumine; Procedure · Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Donor Sites, Wound Heal, Wound Drainage, Pain Management
Interventions: NovaDress, Mepilex Ag, Xeroform; Device
Lead sponsor: Joseph M. Still Research Foundation, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Thyroid Gland Nodule
Interventions: Diagnostic DNA Methylation Signature; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 19 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Chronic Limb-Threatening Ischemia
Interventions: MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes; Device
Lead sponsor: Medistim ASA; Industry
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Soft Tissue Sarcomas
Interventions: Ultra-Hypo-fractionation Radiotherapy, Resection, Questionnaire Administration, Moderately-Hypo-fractionation Radiotherapy; Radiation · Procedure · Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

Vitagel Revision Total Knee Arthroplasty

Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study

Cam Decompression Utilizing the Stryker Hip-Check Software Platform

A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris

Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle

ViBone in Cervical and Lumbar Spine Fusion

Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy

Temporal Investigation of Multimodal Elements

Lanreotide in the Treatment of Small Bowel Motility Disorders

Immediate Postmastectomy Breast Reconstruction (Strattice Breast)

COVID-19 Molecular OTC At Home Test

Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours

Apple Respiratory Study

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery

Comparative Study Evaluating Performance of Celliant Fibers on Tissue Oxygenation

A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation

A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.

Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

Peripheral Bypass Trial for Completion Control

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas